0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Revenue CAGR (3y) in the growth category include:
Three-year compound annual growth rate in revenue.
Revenue CAGR (3y) measures the three-year compound annual growth rate in Revenue.
Compound annual growth rate (CAGR) is a commonly used business and investing term that measures the growth of a metric over multiple periods. CAGRs are useful since they reduce the effect of volatility in specific periods, unlike arithmetic means.
You can find the calculation details for GSK’s Revenue CAGR outlined below. The calculation starts by listing values for Revenue for the last four fiscal years that are required to calculate CAGR:
| Fiscal Year | Revenue | YoY Growth |
|---|---|---|
| 2021-12-31T00:00:00.000Z | 24.696 B | |
| 2022-12-31T00:00:00.000Z | 29.324 B | 18.7% |
| 2023-12-31T00:00:00.000Z | 30.328 B | 3.4% |
| 2024-12-31T00:00:00.000Z | 31.376 B | 3.5% |
Using the values for Revenue listed in the table above, we can calculate three-year Revenue CAGR as follows:
Number of years = 3
Multiplier = £31.376 B / £24.696 B = 1.27
3 Year CAGR = 1.27 ^ (1/3) - 1 = 8.3%
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. GSK’s reports in the GBP currency. You can read more about Revenue here and compound annual growth rate on Wikipedia. You may also find variants five-year Revenue CAGR, and seven-year Revenue CAGR useful.
The chart above depicts the distribution of revenue cagr (3y) for companies operating in the Healthcare sector in the Developed economic region. Over 1,720 companies were considered in this analysis, and 1,655 had meaningful values. The average revenue cagr (3y) of companies in the sector is 15.3% with a standard deviation of 39.5%.
GSK plc DRC's Revenue CAGR (3y) of 8.3% ranks in the 49.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,723 |
| Included Constituents | 1,655 |
| Min | -65.6% |
| Max | 238.3% |
| Median | 8.5% |
| Mean | 15.3% |
| Standard Deviation | 39.5% |
You can find companies with similar revenue cagr (3y) using this stock screener.